Sounding Board: 2019 benefits costs show the sky isn’t falling
At the start of a new decade, it makes sense to look in the rear-view mirror to better understand where the industry is going. For drug plans, a crescendo of forecasts have predicted skyrocketing benefits costs, driven by high-cost drugs. That talk has only increased the cries for a national pharmacare strategy to make drugs more affordable. Looking back […]
- January 16, 2020 November 12, 2020
- 09:30